Learn more

ZIBO QIDINGLI PATENT INF CONSULTING CO LTD

Overview
  • Total Patents
    196
  • GoodIP Patent Rank
    8,502
  • Filing trend
    ⇩ 100.0%
About

ZIBO QIDINGLI PATENT INF CONSULTING CO LTD has a total of 196 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in China. Its main competitors in its focus markets pharmaceuticals, environmental technology and electrical machinery and energy are SICHUAN DERUNTONG BIOTECHNOLOGY CO LTD, YOU XIHUO and HUANG XIULIAN.

Patent filings in countries

World map showing ZIBO QIDINGLI PATENT INF CONSULTING CO LTDs patent filings in countries
# Country Total Patents
#1 China 196

Patent filings per year

Chart showing ZIBO QIDINGLI PATENT INF CONSULTING CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Tian Lihua 169
#2 Gao Zhongqing 15
#3 Wang Shuying 5
#4 Sun Fengfu 4
#5 Gao Wei 2
#6 Xu Liming 2
#7 Sun Jining 1
#8 Zhang Baolong 1
#9 Sun Yuping 1
#10 Wang Lanling 1

Latest patents

Publication Filing date Title
CN106989345A It is a kind of to be applied to student's desk lamp firm under a variety of environment
CN107049853A A kind of shaving cream
CN107049854A A kind of shower cream
CN106906060A A kind of Plant liquid soap
CN106265653A Ternatusine A application in preparing Anti-helicobacter pylori drugs
CN106265639A Linderolide H application in preparation anti-bacteria-free inflammation
CN106361744A Application of Linderolide H in preparing medicine for treating hemorrhagic fever with renal syndrome
CN106361743A Application of Linderolide H to preparation of antibacterial drug
CN106420709A Applications of Linderolide H in preparing medicines for treating or preventing chronic heart failure
CN106361748A Application of Ternatusine A in preparation of medicine for treating kidney cancer
CN106361742A Application of Linderolide H in preparing medicine for ovarian cancer treatment
CN106420766A Application of Friedolanostanes in preparing erythrocyte increasing drugs
CN106361747A Application of Ternatusine A in preparation of drugs for resisting aseptic inflammations
CN106265691A Friedolanostanes application in preparation treats and prevents renal fibrosis medicine
CN106265652A Ternatusine A application in preparation treatment pancreatic cancer drug
CN106265651A Ternatusine A application in preparing medicament for expanding vascellum
CN106265637A Linderolide H promotes the application in small intestinal peristalsis medicine in preparation treatment
CN106420764A Application of Friedolanostanes in preparation of medicine for resisting lung cancer metastasis
CN106265690A Friedolanostanes application in preparation treatment tongue cancer drug
CN106265638A Linderolide H application in preparation treatment or preventing canker sore medicine